Antibody titer after administration of mRNA‐based vaccine against severe acute respiratory syndrome coronavirus 2 in liver transplant recipients

INTRODUCTION: The mRNA‐based vaccine was released as a COVID‐19 prophylactic; however, its efficacy in organ transplant recipients is unknown. This study aimed to clarify this in liver transplant recipients. METHODS: Herein, liver transplant recipients from two hospitals who received vaccines were i...

Descripción completa

Detalles Bibliográficos
Autores principales: Mita, Atsuyoshi, Ohno, Yasunari, Masuda, Yuichi, Yoshizawa, Kazuki, Kubota, Koji, Notake, Tsuyoshi, Shimizu, Akira, Matsunami, Hidetoshi, Soejima, Yuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472375/
https://www.ncbi.nlm.nih.gov/pubmed/37663964
http://dx.doi.org/10.1002/ags3.12677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472375/
https://www.ncbi.nlm.nih.gov/pubmed/37663964
http://dx.doi.org/10.1002/ags3.12677

Ejemplares similares